BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2014
View Archived Issues
Novel single nucleotide polymorphisms associated with bipolar disorder
Read More
NeurOp receives further NIH funding to develop cerebral ischemia candidate
Read More
Clinical data demonstrate the feasibility of roniciclib in SCLC and ovarian cancer
Read More
CellCollector may improve circulating tumor cell collection for breast cancer monitoring
Read More
Novel potent dual kinase EGFR inhibitor synthesized at Innova Pharmaceuticals
Read More
Lexicon Pharmaceuticals reports topline data for LX-4211 in type 1 diabetes
Read More
Cellceutix antibiotic shows activity against drug-resistant K. pneumoniae
Read More
Agios Pharmaceuticals begins phase I study of AG-348 in healthy volunteers
Read More
Alimera Sciences confirms new FDA action date for Iluvien
Read More
Novel sequencing method developed for the GBA gene
Read More
Scripps Research Institute launches new drug discovery initiative
Read More
Bristol-Myers Squibb patents new prodrugs of Notch signaling inhibitors
Read More
Midwestern University discloses novel FTO modulators
Read More
Covagen discloses novel IL-17A bispecific fusion proteins
Read More
NeoStem to acquire California Stem Cell and initiate phase III melanoma trial
Read More
VPM-1002 shows favorable preclinical and early clinical profile for the treatment of bladder cancer
Read More
Aapa BV discloses new SERT inhibitors and 5-HT2C receptor antagonists
Read More
Peginterferon alfa-2b follow-on biologic is noninferior in phase II/III trial
Read More
Ziarco Pharma presents novel SYK kinase inhibitors
Read More
FDA approves clinical trial initiation for Vivolux's mitochondria-targeting agent
Read More
DesignMedix receives NIH grant for antimalarial drug
Read More
FDA accepts NDA filing for Boehringer Ingelheim/Lilly diabetes combination tablet
Read More
Bristol-Myers Squibb files NDA for HIV-1 fixed-dose combination tablet
Read More
Grastek immunotherapy for grass pollen-induced allergic rhinitis approved by FDA
Read More
Phase III Livatag study recommended to continue by safety board
Read More
Critical Pharmaceuticals and University of Nottingham initiate first-in-human trial in osteoporosis
Read More